HIPAA Compliance – US Requirements for Protected Health Information
Contents
What does HIPAA compliance mean?
HIPAA stands for the Health Insurance Portability and Accountability Act, a United States law. In the privacy context, HIPAA compliance means meeting applicable requirements governing protected health information, commonly called PHI.
The rules do not apply automatically to every organization connected with health. Their scope includes specified healthcare providers, health plans and clearinghouses as covered entities, along with business associates. An organization's actual activities and handling of information determine its role.
Why can HIPAA matter to pharmaceutical and healthcare projects?
A company or service provider may process health information on behalf of a regulated organization in a US project. Roles, permitted purposes and contractual arrangements should then be established early. Being based in Europe does not automatically exclude relevant obligations.
HIPAA also does not replace the GDPR. Cross-border projects may involve several applicable frameworks. A broad statement about HIPAA compliance therefore cannot answer every question raised by a particular flow of information.
Which areas require practical assessment?
A project should identify the organizations involved, the information processed and the purposes before mapping applicable requirements.
- Scope: Establish whether the organization is a covered entity, business associate or another type of participant.
- Privacy: Assess permitted uses and disclosures and any authorization required for the intended activity.
- Security: Define appropriate administrative, physical and technical safeguards for electronic PHI.
- Operations: Document contracts, access controls, training and the response to security incidents.
A business associate agreement may be required, but it does not itself provide unrestricted permission to use information for the associate's own marketing.
What matters specifically for marketing?
The HIPAA Privacy Rule includes specific requirements for use or disclosure of PHI for marketing. Written authorization is often required; exceptions and definitions need to be assessed for the circumstances. An ordinary newsletter opt-in should not simply be treated as equivalent.
Patient information, audience selection and external tracking or communication services deserve assessment before deployment. A technical product feature alone cannot establish compliance of the whole process. The actual information flow, organizational role and intended purpose remain decisive.
Distinguish privacy, security and breach notification
The Privacy Rule governs permitted use and disclosure of protected health information. The Security Rule addresses safeguards for electronic PHI. The Breach Notification Rule concerns notification following specified breaches of unsecured PHI. A contract or encrypted connection alone therefore does not address the full set of requirements. A project needs to bring together the obligations applicable to its actual role and activity.
Conclusion: Assess HIPAA by role and information flow
HIPAA compliance requires a concrete understanding of the US health information context. Pharmaceutical and healthcare projects need clear scope, permitted purposes and dependable safeguards. Broad compliance assurances do not replace that assessment.
